Fact CheckerSign in

NCT06697093Recruiting

Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock

Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock CaS-POL

Source: ClinicalTrials.gov · Last updated 2 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support. It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
6 Nov 2024
Start date
1 Apr 2025
Primary completion date
1 Apr 2026
Lead sponsor
Wroclaw Medical University
NCT number
NCT06697093

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 1 Apr 2025 to the primary completion date, 1 Apr 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation

Other

  • patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR)
  • primary septic, anaphylactic, hypovolemic shock
  • post-operative cardiogenic shock

Who the study is looking for

  • Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E.
  • age \> 18 years old
  • persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
Coordinator of this site? Confirm its status
WroclawPolandNot yet recruiting
Wroclaw Medical University
Coordinator of this site? Confirm its status
WroclawPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.